维普中文期刊产品整合服务
12篇 您的检索式:作者名="Clamp AR"
    题名 作者 年代 出处 被引量
1A randomized phase II (RP2) trial of ridaforolimus (R) compared with progestin (P) or chemotherapy (C) in female adult patients with advanced endometrial carcinoma显示文摘Oza A M Poveda A Clamp AR 2011J Clin Oncol2011,29,24:1
2SCOTROC2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer显示文摘Clamp AR MaenpaaJ Cmickshank D 2006BrJ Cancer2006,94,1:1
3Angiogenesis as a therapeutic target in cancer显示文摘Kumaran G Clamp AR Jayson GC 2008Clin Med2008,8,4:1
4A phase I and pharmaco- kinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer显示文摘Clamp AR Schoffski P Valle JW 2008Cancer Chemother Pharmacol2008,61,4:1
5SCOTROC 2B:feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer显示文摘Clamp AR Maenpaa J Cruickshank D 2006Br J Cancer2006,94,1:1
6Heparin octasaccharides inhibit angiogenesis in vivo 显示文摘Hasan J Shnyder SD Clamp AR 2005Clin Cancer Res2005,11,22:1
7Angiogenesis as a therapeutic target in cancer显示文摘Kumaran G Clamp AR Jayson GC 2008Clin Med2008,8,4:1
8Antiangiogenic drugs inovarian cancer显示文摘Kumaran GC Jayson GC Clamp AR 2009British Journal of Cancer2009,100,1:1
9Antiangiogenic drugs in ovarian cancer显示文摘Kumaran GC Jayson GC Clamp AR 2009Br J Cancer2009,100,1:1
10Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor:insights from imaging显示文摘O'Connor JP Carano RA Clamp AR 2009Clin Cancer Res2009,15,21:1
11Quantifying antivascu- lar effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging显示文摘O'Connor JP Clamp AR Carano RA 2009Clin Cancer Res2009,15,21:1
12Antiangiogenic drugs in ovarian cancer显示文摘Kumaran GC Jayson GC Clamp AR 2009Br J Cancer2009,100,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费